Drug
Topical Formulation OF Tacrolimus
Topical Formulation OF Tacrolimus: highest development phase Phase 1, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| topical formulation of tacrolimus NCT03673527 | Phase 1 |
Latest
No recent events.
Follow Topical Formulation OF Tacrolimus on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.